Pharma giant moves past one patent cliff, but another looms

A CNBC report says a pharma giant is getting past one patent cliff while another is already approaching. Disappointing trial data is making it harder to build its next blockbuster medicines.

Timeline

1. 30 Oct, 06:00 UTCFirst appeared on CNBC

Top sources

• A pharma giant is moving past one patent cliff — but another is already loomingCNBC